vTv Therapeutics (VTVT) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for vTv Therapeutics (VTVT) over the last 11 years, with Q4 2024 value amounting to $508000.0.
- vTv Therapeutics' Accumulated Depreciation & Amortization rose 431.21% to $508000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $508000.0, marking a year-over-year increase of 431.21%. This contributed to the annual value of $508000.0 for FY2024, which is 431.21% up from last year.
- vTv Therapeutics' Accumulated Depreciation & Amortization amounted to $508000.0 in Q4 2024, which was up 431.21% from $487000.0 recorded in Q4 2023.
- vTv Therapeutics' 5-year Accumulated Depreciation & Amortization high stood at $508000.0 for Q4 2024, and its period low was $216000.0 during Q4 2020.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $397000.0 (2022), whereas its average is $382600.0.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first surged by 4594.59% in 2020, then surged by 431.21% in 2024.
- vTv Therapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $216000.0 in 2020, then soared by 41.2% to $305000.0 in 2021, then soared by 30.16% to $397000.0 in 2022, then increased by 22.67% to $487000.0 in 2023, then rose by 4.31% to $508000.0 in 2024.
- Its last three reported values are $508000.0 in Q4 2024, $487000.0 for Q4 2023, and $397000.0 during Q4 2022.